These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 902673

  • 21. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J, Blair AD, Cutler RE.
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [Abstract] [Full Text] [Related]

  • 22. Plasma and urinary kinetics of furosemide in newborn infants.
    Tuck S, Morselli P, Broquaire M, Vert P.
    J Pediatr; 1983 Sep; 103(3):481-5. PubMed ID: 6886918
    [Abstract] [Full Text] [Related]

  • 23. Renal tubular secretion and effects of furosemide.
    Odlind B, Beermann B.
    Clin Pharmacol Ther; 1980 Jun; 27(6):784-90. PubMed ID: 7379446
    [Abstract] [Full Text] [Related]

  • 24. Furosemide kinetics and dynamics in patients with cirrhosis.
    Villeneuve JP, Verbeeck RK, Wilkinson GR, Branch RA.
    Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
    [Abstract] [Full Text] [Related]

  • 25. Effect of furosemide on urinary excretion of 4-hydroxy-3-methoxymandelic acid (VMA).
    Bursztyn M, Gutman A.
    Isr J Med Sci; 1985 Sep; 21(9):742-4. PubMed ID: 4055336
    [Abstract] [Full Text] [Related]

  • 26. Absorption and disposition of furosemide in congestive heart failure.
    Brater DC, Seiwell R, Anderson S, Burdette A, Dehmer GJ, Chennavasin P.
    Kidney Int; 1982 Aug; 22(2):171-6. PubMed ID: 7132061
    [Abstract] [Full Text] [Related]

  • 27. Frusemide and its acyl glucuronide show a short and long phase in elimination kinetics and pharmacodynamic effect in man.
    Vree TB, Van Den Biggelaar-Martea M, Verwey-Van Wissen CP.
    J Pharm Pharmacol; 1995 Nov; 47(11):964-9. PubMed ID: 8708993
    [Abstract] [Full Text] [Related]

  • 28. Furosemide absorption altered in decompensated congestive heart failure.
    Vasko MR, Cartwright DB, Knochel JP, Nixon JV, Brater DC.
    Ann Intern Med; 1985 Mar; 102(3):314-8. PubMed ID: 3970471
    [Abstract] [Full Text] [Related]

  • 29. Inhibition of renal clearance of furosemide by pentopril, an angiotensin-converting enzyme inhibitor.
    Rakhit A, Kochak GM, Tipnis V, Hurley ME.
    Clin Pharmacol Ther; 1987 May; 41(5):580-6. PubMed ID: 3032491
    [Abstract] [Full Text] [Related]

  • 30. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V, Seferovic P, Dodic S, Krotin M, Neskovic A, Dickstein K, de Voogd H, Böcker C, Ziegler D, Godes M, Nakov R, Essers H, Verboom C, Hocher B.
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [Abstract] [Full Text] [Related]

  • 31. Hemodynamic effects of nitroprusside and furosemide in left ventricular failure.
    Franciosa JA, Silverstein SR.
    Clin Pharmacol Ther; 1982 Jul; 32(1):62-9. PubMed ID: 7083731
    [Abstract] [Full Text] [Related]

  • 32. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.
    Paterna S, Di Pasquale P, Parrinello G, Amato P, Cardinale A, Follone G, Giubilato A, Licata G.
    Eur J Heart Fail; 2000 Sep; 2(3):305-13. PubMed ID: 10938493
    [Abstract] [Full Text] [Related]

  • 33. [Renal effects of ibopamine in comparison with furosemide in patients with mild heart failure].
    Wehling M, Zimmermann J, Weil J, Gerzer R, Theisen K.
    Z Kardiol; 1990 Feb; 79(2):120-5. PubMed ID: 2157313
    [Abstract] [Full Text] [Related]

  • 34. Clinical pharmacokinetics of furosemide in children with nephrotic syndrome.
    González-Martín G, Bravo I, Ibarra N, Arancibia A.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):598-601. PubMed ID: 6668097
    [Abstract] [Full Text] [Related]

  • 35. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT, Watanabe K, Ma M, Palaniyandi SS, Yamaguchi K, Kodama M, Aizawa Y.
    Biochem Pharmacol; 2008 Mar 15; 75(6):1322-30. PubMed ID: 18179782
    [Abstract] [Full Text] [Related]

  • 36. Furosemide disposition in cirrhotic patients.
    Sawhney VK, Gregory PB, Swezey SE, Blaschke TF.
    Gastroenterology; 1981 Dec 15; 81(6):1012-6. PubMed ID: 7286579
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. High dose furosemide in refractory cardiac failure.
    Kuchar DL, O'Rourke MF.
    Eur Heart J; 1985 Nov 15; 6(11):954-8. PubMed ID: 4076205
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.